Name: Latest research reports of Alembic Pharmaceuticals Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alembic Pharmaceuticals Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Mid-range Performer

976.6000 -0.50 (-0.05%)

NSE Jul 11, 2025 15:31 PM

25.10% Fall from 52W High

Volume: 60,016

Alembic Pharmaceuticals Ltd.

09 May 2024

976.60

-0.05%

Alembic Pharma (HOLD): Strong margins; positives priced in

Hold: Alembic Pharmaceuticals Ltd.

BOB Capital Markets Ltd.

ALPM reported strong margin gains in Q4 on account of better utilisation of new facilities and traction in the US business

Alembic Pharmaceuticals Ltd. is trading below its 30 day SMA of 980.8